PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.73%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-8.23%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-44.22%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-44.22%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
56.92%
Positive net income growth while MTDR is negative. John Neff might see a big relative performance advantage.
58.82%
Positive EPS growth while MTDR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
55.15%
Positive diluted EPS growth while MTDR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.30%
Slight or no buybacks while MTDR is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.15%
Slight or no buyback while MTDR is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-3.05%
Dividend reduction while MTDR stands at 0.08%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
32.55%
Positive OCF growth while MTDR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
79.57%
Positive FCF growth while MTDR is negative. John Neff would see a strong competitive edge in net cash generation.
-14.59%
Negative 10Y revenue/share CAGR while MTDR stands at 690.14%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-14.59%
Negative 5Y CAGR while MTDR stands at 1272.50%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-14.59%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.93%
Below 50% of MTDR's 163.75%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
24.93%
Below 50% of MTDR's 139.65%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
24.93%
Positive short-term CAGR while MTDR is negative. John Neff would see a clear advantage in near-term profit trajectory.
165.80%
10Y equity/share CAGR at 50-75% of MTDR's 274.37%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
165.80%
5Y equity/share CAGR at 75-90% of MTDR's 204.54%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
165.80%
3Y equity/share CAGR above 1.5x MTDR's 101.40%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.60%
AR growth well above MTDR's 2.38%. Michael Burry fears inflated revenue or higher default risk in the near future.
28.21%
Inventory growth well above MTDR's 23.07%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.22%
Asset growth 1.25-1.5x MTDR's 1.79%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
5.43%
BV/share growth above 1.5x MTDR's 2.09%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-7.99%
We’re deleveraging while MTDR stands at 0.54%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
315.92%
We expand SG&A while MTDR cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.